6 Results for "

B-cell blood cancers

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "B-cell blood cancers" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-13747
CAS No.: 13909-09-6
Purity:  ≥98.0%
Research Areas:  

Cancer

Semustine is an orally active, blood-brain barrier permeable antitumor alkylating agent with a binding affinity of 1.53 × 10 3 M -1 for guanine and thymine residues in bovine DNA. Semustine undergoes major groove-directed alkylation at guanine residues to form O6-chloroethylguanine and N1-O6-ethanoguanine adducts, and generates dG-dC interstrand crosslinks. Semustine induces partial B- to C-type transition of DNA, base stacking and helical structure distortion, mild dehydration, as well as partial DNA double-strand unwinding. Semustine can be used in research related to Lewis lung cancer, leukemia, Hodgkin's lymphoma, malignant melanoma, glioma, and diffuse large B-cell lymphoma .
loading...
    loading...
Cat. No.: HY-160142
CAS No.: 2884554-45-2
Target:  

PROTACs Btk Syk MEK ERK

Research Areas:  

Cancer

UBX-382 is an orally active BTK PROTAC degrader with a DC50 of 4.56 nM. UBX-382 inhibits B-cell receptor signaling by targeting BTK. UBX-382 shows superior degradation activity for wild-type and mutant BTK proteins. UBX-382 inhibits tumor growth in murine xenograft models harboring wild-type or C481S mutant BTK-expressing TMD-8 cells. UBX-382 can be used for the study of B-cell-related blood cancers .
loading...
    loading...
Cat. No.: HY-182910
Target:  

PROTACs Btk

Research Areas:  

Cancer

PROTAC BTK Degrader-15 is a heterobifunctional molecule and PBLEC 4 that catalyzes degradation of BTK. PROTAC BTK Degrader-15 can be used for the research of b-cell blood cancers .
loading...
    loading...
Cat. No.: HY-182911
CAS No.: 4543-39-9
Target:  

Ligands for E3 Ligase

Research Areas:  

Cancer

Cereblon ligand-5 is a cereblon ligand that recruits the CRBN protein. Cereblon ligand-5 can be linked to the BTK target protein ligand via a linker to form PROTAC BTK Degrader-15 (HY-182910) .
loading...
    loading...
Cat. No.: HY-182933
Research Areas:  

Cancer

BTK ligand-20 (compound 1) is a BTK ligand. BTK ligand-20 serves as a target protein ligand for the synthesis of PROTAC BTK Degrader-15 (HY-182910). BTK ligand-20 is applicable to cancer research .
loading...
    loading...
Cat. No.: HY-P991918
Synonyms: IgG2-AAS
KHK2840 is a potent CD40 agonist with a Kd value of 0.485 nM for hCD40. KHK2840 delivers agonistic signals in tumor-bearing hCD40 transgenic mice and human peripheral blood B cells. KHK2840 upregulates CD80, CD86, CD95 and IL-12p70 expression. KHK2840 enhances antitumor efficacy of anti-PD-1 antibody and Paclitaxel (HY-B0015). KHK2840 can be used for the research of cancer, such as colon cancer and melanoma .
loading...
    loading...